ASSESSMENT OF TP53, PTEN AND AKT GENE MUTATIONS IN TONGUE SQUAMOUS CELL CARCINOMA AND ORAL LEUKOPLAKIA OF SMOKERS AND NON-SMOKERS
DOI:
https://doi.org/10.5327/2525-5711.337Keywords:
TP53, PTEN, AKT, Loss of Heterozygosity, Smoking behaviorAbstract
Oral Squamous Cell Carcinoma (OSCC) is the most common malignant tumor of the oral cavity. It can be preceded by Oral leukoplakia (OL), the most prevalent potentially malignant disorder, which presents a malignant transformation rate which varies from 1,1% to 40,8%, found most commonly in tongue lesions. Smoking is a well-established risk factor for both OL and OSCC. In this study we aimed to investigate loss of heterozygosity (LOH) as well as the frequency and patterns of the mutations in the PTEN, AKT and TP53 genes in OL and tongue squamous cell carcinoma (TSCC) samples of smokers and non-smokers patients. Tissue specimens were obtained from 73 patients: 35 cases of TSCC and 38 cases of high grade OL occurring in the lateral border of the tongue, and PTEN, AKT e TP53 gene mutations were investigated through Fluorescence In Situ Hybridization and genotyping. Differences between the genetic changes studied in the TP53, PTEN and AKT genes in smoking and non-smoking patients were detected. Changes in the TP53 gene did not occur significantly in the OL stage in either smoking or non-smoking patients, whereas changes in the PTEN gene were observed in both OL and OSCC, with a statistically significant difference between smokers and non-smokers. Furthermore, changes in the AKT gene did not occur with high frequency in either OL or carcinomas, regardless of smoking status, suggesting that disruptions in the critical PI3K pathway are primarily due to genetic changes in PTEN rather than in the AKT gene.
References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J.
- Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021 Nov;27(8):1881-1895.
- Miyahara LAN, Pontes FSC, Burbano R MR, Neto NC, Guimarães DM, Fonseca FP, et al . PTEN allelic loss is an important mechanism in the late stage of development of oral leukoplakia into oral squamous cell carcinoma. Histopathology 2018; 72(2):330-338.
- Christine A, Park MK, Song SJ, Song MS. The equilibrium of tumor suppression: DUBs as active regulators of PTEN. Exp Mol Med 2022; 54(11):1814-1821.
- Kerdjoudj M, La Torre RA, Arnouk H . Characterization of DJ-1, PTEN, and p-Akt as Prognostic Biomarkers in the Progression of Oral Squamous Cell Carcinoma. Cureus 2023; 31 15(1):e34436.
- Sundberg J, Pandey S, Giglio D, Holmberg E, Kjeller G, Kovács A, et al. Expression of p53, p63, podoplanin and Ki‑67 in recurring versus non‑recurring oral leukoplakia. Nature portfolio 2021; 11:20781.
-Chen H, Liu X, Jin Z, Gou C, Liang M, Cui Li, et al. A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. Am J Cancer Res 2018; 8(8):1403-1413.
- Martins F, de Sousa SC, dos Santos E, Woo SB, Gallottini M . PI3K–AKT–mTOR pathway proteins are differently expressed in oral carcinogenesis. J Oral Pathol Med 2016; 45(10):746-752.
- Kujan O, Oliver R J, Khattab A, Roberts S A, Thakker N, Sloa P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42(10):987-93.
- Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Diseases. 2021; 00:1–30.
- Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83:2934– 2938.
- Calcagno DQ, Leal MF, Taken SS, Assumpcao PP, Demachki S, Demachki S, et al. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer res 2005; 25:4069–4074.
- Hopman AH, Ramaekers FC, Raap AK, Beck JL, Devilee P, Ploeg MV, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988; 89:307–316.
- Starzyńska A, Sejda A, Adamska P, Marvaso G, Sakowicz-Burkiewicz M, Adamski Łukasz, et al. Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review. Arch Med Sci 2020; 17(1): 207-217.
- Das D, Maitra A, Panda CK, Ghose S, Roy B, Sarin R, Majumder PP. Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivobuccal oral cancer. NPJ Genom Med 2021; 6(1):32.
- Batta N, Pandey M. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol 2019; 17(1):198.
- Hyodo T, Kuribayashi N, Fukumoto C, Komiyama Y, Shiraishi R, Kamimura R, et al. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications. Sci Rep 2022; 12(1):21695.
- Nakagaki T, Tamura M, Kobashi K, Koyama R, Fukushima H, Ohashi T, et al . Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing. Oncotarget 2017; 8(35):59113-59122.
- Kato V J O, Abreu M C, Kato A M B, Pontes FSC, Sant'anna CC, Junior AGJ, et al. Significance of P16INK4A Expression and PTEN Loss of Heterozygosity in Human Papilloma Virus-related Oral Squamous Cell Carcinoma. Anticancer Research 2020; 40:6355-6366.
- Wang Y, Lin L, Xu H, Zhou Y, Dan H, Jiang L, et al . Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population. J Oral Pathol Med 2015; 44(1),45-50.
- Yi KH, Lauring J. Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity. Oncotarget 2016; 7(4):4241-51.
- Chaves FN, Bezerra TMM, Moraes D C, Costa SFS, Silva PGB, Alves APNN, et al . Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma. Exp Mol Pathol 2020; 112:104341.
- Guimarães L M; Diniz M G; Rogatto S R; Gomez R S, Gomes C C . The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis. J Oral Pathol Med 2021; 50(7):632-638.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Glauce Guimarães Pereira , Flávia Sirotheau Côrrea Pontes , Carolina Cavalieri Gomes , Felipe Paiva Fonseca, Ana Luisa Sirotheau Corrêa Pontes, Sue Ann Lavareda Corrêa Uchoa, Samara Silveira da Cruz, Rommel Mario Rodriguez Burbano, Hélder Antônio Rebelo Pontes

This work is licensed under a Creative Commons Attribution 4.0 International License.